Literature DB >> 23701180

Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches.

Esteban Orenes-Piñero1, Diana Hernández-Romero, Carlos de Torre, Juan Antonio Vilchez, Marina Martínez, Ana Isabel Romero-Aniorte, Vicente Climent, Antonio García-Honrubia, Mariano Valdés, Francisco Marín.   

Abstract

INTRODUCTION: Aiming at identifying biomarkers for hypertrophic cardiomyopathy (HCM), the serum proteome was explored through a two-dimensional gel-based proteomic approach (2D-DIGE) coupled with mass spectrometry and database interrogation.
METHODS: Serum samples from 20 male HCM patients and their sex- and age-matched controls were cleaned from interfering components. Patients and controls were pooled in five matched groups with the same age, and proteins extracts from each pool were labelled with cyanine dyes. Then, gel images were analysed using a fluorescence scanner and proteins were identified. Tryptic peptides were analysed by capillary reversed-phase liquid chromatography coupled online with tandem mass spectrometry (MS/MS).
RESULTS: Four different proteins were observed to be differentially expressed between HCM patients and their matched controls. Of them, decreases in haptoglobin levels were confirmed to be associated with HCM in an independent set of 181 consecutive HCM patients from our monographic clinic and 114 controls with similar age and sex using a nephelometer-based technique. Moreover, a significant negative correlation was observed between haptoglobin and subaortic gradient, thus highlighting the role of haptoglobin in HCM.
CONCLUSION: All these observations point out the utility of the 2D-DIGE proteomic strategy for the identification of serum proteins indicative of the presence of cardiac injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23701180     DOI: 10.3109/07853890.2013.792555

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  2 in total

1.  Application of Proteomics Profiling for Biomarker Discovery in Hypertrophic Cardiomyopathy.

Authors:  Yuichi J Shimada; Kohei Hasegawa; Stephanie M Kochav; Pouya Mohajer; Jeeyoun Jung; Mathew S Maurer; Muredach P Reilly; Michael A Fifer
Journal:  J Cardiovasc Transl Res       Date:  2019-07-05       Impact factor: 4.132

Review 2.  What Room for Two-Dimensional Gel-Based Proteomics in a Shotgun Proteomics World?

Authors:  Katrin Marcus; Cécile Lelong; Thierry Rabilloud
Journal:  Proteomes       Date:  2020-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.